| |
| |
|
| Insider
Information: |
Watts Ryan J. |
| Relationship: |
President and CEO, Dir... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
238,067 |
|
|
Indirect Shares
|
2,202,604 |
|
|
| Direct
Value |
$4,935,129 |
|
|
|
Indirect Value
|
$45,659,981 |
|
|
| Total
Shares |
2,440,671 |
|
|
| Total
Value |
$50,595,110 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 122.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
President and CEO, Dir... |
2024-03-29 |
238,067 |
2024-03-29 |
2,202,604 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2017-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2018-08-29 |
4 |
AS |
$18.05 |
$330,929 |
I/I |
(18,334) |
2,784,304 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2018-09-04 |
4 |
AS |
$19.06 |
$349,427 |
I/I |
(18,333) |
2,765,971 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2018-10-01 |
4 |
AS |
$21.72 |
$398,193 |
I/I |
(18,333) |
2,747,638 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2018-11-13 |
4 |
AS |
$18.00 |
$85,428 |
I/I |
(4,746) |
2,742,892 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2018-11-15 |
4 |
AS |
$18.12 |
$246,236 |
I/I |
(13,588) |
2,729,304 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2018-11-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
40,000 |
2,689,304 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2018-12-03 |
4 |
AS |
$18.42 |
$337,938 |
I/I |
(18,333) |
2,670,971 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-01-02 |
4 |
AS |
$19.42 |
$118,311 |
I/I |
(6,050) |
2,664,921 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-01-03 |
4 |
AS |
$18.89 |
$114,285 |
I/I |
(6,050) |
2,658,871 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-01-04 |
4 |
AS |
$19.18 |
$123,693 |
I/I |
(6,233) |
2,652,638 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-02-01 |
4 |
AS |
$18.65 |
$112,833 |
I/I |
(6,050) |
2,646,588 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-02-04 |
4 |
AS |
$18.49 |
$75,496 |
I/I |
(4,054) |
2,642,534 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-02-05 |
4 |
AS |
$18.83 |
$154,971 |
I/I |
(8,230) |
2,634,304 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-03-01 |
4 |
AS |
$22.19 |
$135,726 |
I/I |
(6,050) |
2,628,254 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-03-04 |
4 |
AS |
$21.87 |
$135,958 |
I/I |
(6,142) |
2,622,112 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-03-05 |
4 |
AS |
$21.97 |
$134,918 |
I/I |
(6,141) |
2,615,971 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-04-01 |
4 |
AS |
$23.91 |
$144,656 |
I/I |
(6,050) |
2,609,921 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-04-02 |
4 |
AS |
$24.52 |
$152,514 |
I/I |
(6,142) |
2,603,779 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-04-03 |
4 |
AS |
$26.28 |
$161,630 |
I/I |
(6,141) |
2,597,638 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-05-01 |
4 |
AS |
$24.09 |
$147,238 |
I/I |
(6,112) |
2,591,526 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-05-02 |
4 |
AS |
$24.03 |
$146,847 |
I/I |
(6,111) |
2,585,415 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-05-03 |
4 |
AS |
$24.49 |
$149,658 |
I/I |
(6,111) |
2,579,304 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-05-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
40,000 |
2,520,971 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-06-03 |
4 |
AS |
$19.07 |
$349,610 |
I/I |
(18,333) |
2,560,971 |
0 |
- |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
